Elicio Therapeutics Inc./$ELTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
Ticker
$ELTX
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
32
ISIN
US28657F1030
Website
ELTX Metrics
BasicAdvanced
$129M
-
-$3.98
-
-
Price and volume
Market cap
$129M
52-week high
$9.00
52-week low
$4.60
Average daily volume
50K
Financial strength
Current ratio
1.834
Quick ratio
1.608
Long term debt to equity
54.638
Total debt to equity
65.038
Interest coverage (TTM)
-76.44%
Profitability
EBITDA (TTM)
-45.189
Management effectiveness
Return on assets (TTM)
-108.03%
Return on equity (TTM)
-744.59%
Valuation
Price to book
14.44
Price to tangible book (TTM)
14.44
Price to free cash flow (TTM)
-2.948
Free cash flow yield (TTM)
-33.92%
Free cash flow per share (TTM)
-273.09%
Growth
Earnings per share change (TTM)
-22.93%
3-year earnings per share growth (CAGR)
33.42%
ELTX News
AllArticlesVideos
Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer
GlobeNewsWire·1 week ago
Elicio Therapeutics Secures $10 Million in Financing
GlobeNewsWire·3 weeks ago
Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Elicio Therapeutics Inc. stock?
Elicio Therapeutics Inc. (ELTX) has a market cap of $129M as of June 25, 2025.
What is the P/E ratio for Elicio Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Elicio Therapeutics Inc. (ELTX) stock is 0 as of June 25, 2025.
Does Elicio Therapeutics Inc. stock pay dividends?
No, Elicio Therapeutics Inc. (ELTX) stock does not pay dividends to its shareholders as of June 25, 2025.
When is the next Elicio Therapeutics Inc. dividend payment date?
Elicio Therapeutics Inc. (ELTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Elicio Therapeutics Inc.?
Elicio Therapeutics Inc. (ELTX) does not currently have a Beta indicator.